Revenue: The sum of all revenue fields included for a company's operating activities.
Collegium Pharmaceutical, Inc. (COLL) had Revenue of $188.00M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$188.00M |
$11.98M |
|
$79.62M |
|
$108.38M |
|
$152.90M |
|
$35.10M |
|
$-18.08M |
|
$17.02M |
|
$17.02M |
|
$11.98M |
|
$11.98M |
|
$11.98M |
|
$11.98M |
|
$35.10M |
|
$91.45M |
|
31.81M |
|
39.08M |
|
$0.38 |
|
$0.34 |
|
| Balance Sheet Financials | |
$549.21M |
|
$12.90M |
|
$1.04B |
|
$1.59B |
|
$464.61M |
|
$758.34M |
|
$895.82M |
|
$1.36B |
|
$232.21M |
|
$-696.19M |
|
$232.21M |
|
31.55M |
|
| Cash Flow Statement Financials | |
$127.84M |
|
$-12.60M |
|
$-73.61M |
|
$96.61M |
|
$138.25M |
|
$41.64M |
|
$22.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.18 |
|
-- |
|
-- |
|
0.77 |
|
3.54 |
|
57.65% |
|
18.67% |
|
18.67% |
|
-- |
|
9.06% |
|
6.37% |
|
$126.97M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
2.09 |
|
0.88 |
|
101.98 |
|
5.16% |
|
-1.72% |
|
0.75% |
|
1.21% |
|
$7.36 |
|
$3.25 |
|
$3.27 |
|